Updated · AI-assisted evidence analysis
Hip + Joint Support Chews for Dogs Review 2026: What Does the Evidence Show?
Hip + Joint chews rest on thin, mixed dog evidence for their blend — Overhyped
-
"Supports healthy joints, cartilage and mobility"
Green-lipped mussel beat placebo in several dog trials. Glucosamine plus chondroitin, the label's headline pair, scored poorly in a 2022 review that pooled dogs and cats, so its result is not a dog-only finding. The dog studies tested other products and mostly dogs with diagnosed arthritis, so none shows this chew works.
Evaluation of the comparative efficacy of green lipped mussel plus krill oil extracts (EAB-277), <i>Biota orientalis</i> extracts or NSAIDs for the treatment of dogs with osteoarthritis associated pain: a blinded, placebo-controlled study. → · Evaluating Complementary Therapies for Canine Osteoarthritis Part I: Green-lipped Mussel (Perna canaliculus). → · A 2022 Systematic Review and Meta-Analysis of Enriched Therapeutic Diets and Nutraceuticals in Canine and Feline Osteoarthritis. → -
"Glucosamine sulfate has 'much higher efficacy' than glucosamine HCl"
The review the page cites calls glucosamine and chondroitin evidence limited and conflicting, and the retrieved abstract is about the HCl form. No sulfate-versus-HCl dog comparison appeared in the material reviewed.
-
"Organic turmeric may help relieve inflammation from normal activity"
A placebo-controlled trial of a turmeric extract in 61 arthritic dogs found no difference in the main objective measure. A mussel-curcumin blend also matched placebo on the vet's score and showed no difference on owner scores or the force plate. No study tested normal-exercise inflammation.
-
"PRIOME postbiotic studied for supporting healthy weight"
No dog study of this postbiotic and weight turned up in this search. The only PRIOME paper retrieved was lab and worm work on different strains for joint cells.
Claims vs Evidence
4 claims assessed. Support depends on the study results, formulation, and population. Matching an ingredient or dose alone does not establish a benefit.
"Supports healthy joints, cartilage and mobility"
Stretch
Ingredient grades: green-lipped mussel partial; glucosamine, chondroitin, hyaluronic acid and turmeric stretch; MSM no_evidence. Mussel trials used other products and mostly dogs with arthritis, not healthy dogs. The 2022 glucosamine-chondroitin review pooled dogs and cats and no dog-only result was in the supplied text, so it is cited as context, not as a dog evidence row. Label amounts have no dog reference range to compare against. No trial of this chew was found.
Green-lipped mussel plus krill oil (EAB-277) vs meloxicam, 4CYTE or placebo
Block-randomized, double-blinded, placebo-controlled trial; full text excerpt only partly read · different formulation
Peak vertical force and orthopedic score improved more than placebo in the EAB-277 and meloxicam groups.
Limitations: Product also contained krill oil; owner-reported outcomes and dose not available in the excerpt; short duration.
- Species
- dog
- Participants / condition
- 101 pet dogs with clinical hip osteoarthritis pain
- Formulation
- Green-lipped mussel plus krill oil extracts (Antinol Rapid, EAB-277); not this chew
- Studied amount, not dosing advice
- Not reported in the retrieved text
- Duration
- 6 weeks
- Funding / conflicts
- Funded by Pharmalink International Ltd.; authors state the funder was not involved in design, analysis or writing.
Green-lipped mussel vs carprofen vs placebo
Randomized, double-controlled, double-blinded trial; abstract only · ingredient
More GLM dogs improved than placebo on vet-assessed mobility, owner pain index and pain scale; not as effective as carprofen.
Limitations: Abstract only; dose unavailable; single ingredient, not a blend; modest sample.
- Species
- dog
- Participants / condition
- 45 dogs with chronic pain and radiographic osteoarthritis who completed the study
- Formulation
- Green-lipped mussel preparation; exact composition not reported
- Studied amount, not dosing advice
- Not reported in the abstract
- Duration
- 8 weeks
- Funding / conflicts
- Not reported in the retrieved abstract.
PCSO-524 in small dogs with patellar luxation
Placebo-controlled study; abstract only · ingredient
Within the treated group, lameness scores improved within 8 weeks, cartilage lesions on ultrasound improved within 4 weeks, and synovial fluid scores decreased by week 4. Only the radiographic OA scores were contrasted with the control group: they improved mildly at 12 weeks in treated dogs versus progression in controls.
Limitations: Very small groups, small-breed dogs with a specific condition, abstract only. The abstract reports lameness, ultrasound and synovial fluid changes as within-group improvements, not as placebo comparisons.
- Species
- dog
- Participants / condition
- 25 dogs (21 with grade II medial patellar luxation, 4 healthy reference), Pomeranian and Chihuahua
- Formulation
- PCSO-524 green-lipped mussel extract
- Studied amount, not dosing advice
- 50 mg daily per dog
- Duration
- 16 weeks
- Funding / conflicts
- Not reported in the retrieved abstract.
"Eases occasional joint stiffness due to normal exercise and activity"
Stretch
Dog trials of Boswellia or blends enrolled dogs with diagnosed arthritis, not dogs with exercise-related stiffness. Boswellia studies used other products or blends. Hyaluronic acid dog evidence in the retrieved material was limited. No Boswellia ingredient record was supplied, so this is capped at stretch.
UC-II plus Boswellia serrata chew, crossover vs placebo
Randomized, double-blind, placebo-controlled crossover trial · different formulation
Owner evaluation showed improved mobility impairment already at 4 weeks of supplementation.
Limitations: Very small sample; collagen is a second active, so Boswellia's own effect is unclear.
- Species
- dog
- Participants / condition
- 17 dogs with mild to moderate osteoarthritis (of 60 screened)
- Formulation
- Chew containing undenatured type II collagen and Boswellia serrata; not this product
- Studied amount, not dosing advice
- 1 chew per day; Boswellia amount not reported in the retrieved text
- Duration
- 8 weeks per period with 4-week washout
- Funding / conflicts
- Funded by Vetoquinol SA; a Vetoquinol employee took part in design and monitoring.
Boswellia resin open trial
Open, uncontrolled multicentre trial; abstract only · ingredient
Overall efficacy seen in 71% of 24 eligible dogs at 2 weeks; lameness, pain and stiff gait scores reduced by 6 weeks.
Limitations: No placebo group; subjective scoring; abstract only; a different extract and dose than the 50 mg in this chew.
- Species
- dog
- Participants / condition
- 29 dogs with chronic joint and spinal disease (osteoarthritis confirmed radiologically in 25)
- Formulation
- Boswellia serrata resin extract BSB108
- Studied amount, not dosing advice
- 400 mg per 10 kg body weight once daily
- Duration
- 6 weeks
- Funding / conflicts
- Not reported in the retrieved abstract; the extract is a product of Bogar AG.
"Organic turmeric may help relieve inflammation associated with normal daily exercise and activity"
Stretch
Dog turmeric evidence is mixed and comes from arthritic dogs, not normal activity. The best-controlled trials found no objective benefit. The page's own turmeric link covers curcumin as a dog-food antioxidant, not joints.
P54FP turmeric extract vs placebo
Randomized, double-blind, placebo-controlled parallel-group trial; abstract only · different formulation
No significant difference in peak vertical force. Investigators' overall assessment favored P54FP (P=0.012); owners' assessment just missed significance (P=0.063).
Limitations: Objective measure was null; different extract; abstract only.
- Species
- dog
- Participants / condition
- 61 client-owned dogs with elbow or hip osteoarthritis (25 treated, 29 placebo analysed)
- Formulation
- P54FP, an extract of Curcuma domestica and C. xanthorrhiza; not this chew
- Studied amount, not dosing advice
- Twice daily; mg amount not reported in the abstract
- Duration
- 8 weeks
- Funding / conflicts
- Not reported in the retrieved abstract.
Green-lipped mussel, curcumin and blackcurrant leaf supplement
Double-blind, randomized, placebo-controlled crossover trial; dog results only used here · different formulation
Vet COAST score improved from baseline but did not differ from placebo; no differences on owner pain index or force plate.
Limitations: Blend makes curcumin's role unclear; small sample; several non-responders noted.
- Species
- dog
- Participants / condition
- 32 client-owned dogs with mild to moderate osteoarthritis (16 cats excluded from this row)
- Formulation
- Supplement combining green-lipped mussel, curcumin and blackcurrant leaf extract; not this chew
- Studied amount, not dosing advice
- Not reported in the retrieved text
- Duration
- 16 weeks in dogs
- Funding / conflicts
- Not reported in the retrieved excerpt.
"PRIOME postbiotic studied for its role in supporting healthy weight, which is important for joint health over time"
No evidence found
No dog study of PRIOME Metabolic Health Postbiotic (B. animalis CECT 8145) and weight turned up in this search. The one PRIOME paper retrieved is a lab study on different strains and joint cells, so it is described in research_scope rather than graded here.
Source: Hip + Joint Support Chews for Dogs: manufacturer product page →
Signals
- The '3rd Party Tested' claim names no lab, seal or test report in the reviewed page.
- The page says glucosamine sulfate has 'much higher efficacy' than HCl, but the review it cites calls the evidence limited and conflicting.
- 'Vet Created' and 'Best Seller' are marketing labels, not evidence that the chew works.
- Testimonials say the ingredients are 'proven', but the dog trials found were mixed and none tested this chew.
- Nine of the eleven actives are listed in mg per chew, not per multi-chew serving; vitamin E is listed in IU and the postbiotic in HTC.
- The postbiotic strain (Bifidobacterium animalis CECT 8145) and count (2.5 billion HTC) are listed.
- The page gives a weight-based serving table and lists inactive ingredients.
Dose vs studies
Label amounts at the label's daily directions, per kg of body weight, compared with what dogs studies used. This compares the label with research. It is not dosing advice.
Label: 500 mg per chew
Studied: No established amount in dogs
Label: 400 mg per chew
Studied: No established amount in dogs
Label: 125 mg per chew
Studied: No established amount in dogs
Label: 50 mg per chew
Studied: No established amount in dogs
Label: 50 mg per chew
Studied: No established amount in dogs
Label: 10 mg per chew
Studied: No established amount in dogs
Evidence checks
Species and formulation relevance
All graded dog evidence is from dogs, but none tested this chew. Trials used single ingredients, other blends or extracts, mostly in dogs with diagnosed arthritis rather than healthy dogs. The 2022 glucosamine-chondroitin review pooled dogs and cats and is not used as a dog evidence row. Label amounts could not be compared with a studied dog range because the ingredient records set none. MSM had no dog results in what was retrieved.
Label transparency
The page lists per-chew mg for nine actives; vitamin E is given in IU and the postbiotic as 2.5 billion HTC. It also gives the postbiotic strain, inactive ingredients and a weight-based serving table. Amounts were read from the page; label images were not independently checked. The page says 'proprietary blend' alongside listed amounts.
Independent quality testing
The page says each batch is tested by a 3rd party lab for potency and purity, but names no lab and shows no certificate or results. No quality-seal record for this company was in the reviewed material. Independent verification is unknown here, not shown to be absent.
Study funding and strength
Several supporting dog trials were small, short or abstract-only. Some were industry-funded (Pharmalink, Vetoquinol). The abstract-only patellar luxation study reports most improvements within the treated group rather than against placebo. A 2022 meta-analysis pooling dogs and cats found chondroitin-glucosamine products showed a marked non-effect on pain; it reported no proprietary funding but its authors disclosed prior work for many pharma and pet-food companies.
Sources (11)
- 1. Hip + Joint Support Chews for Dogs: manufacturer product page →
Manufacturer · Accessed 2026-11-14
- 2. Glucosamine and chondroitin use in canines for osteoarthritis: A review. →
Research review · Accessed 2026-11-14
- 3. A 2022 Systematic Review and Meta-Analysis of Enriched Therapeutic Diets and Nutraceuticals in Canine and Feline Osteoarthritis. →
Research review · Accessed 2026-11-14
- 4. Randomised, double-blind, placebo-controlled parallel group study of P54FP for the treatment of dogs with osteoarthritis. →
Study · Accessed 2026-11-14
- 5. The efficacy of a nutritional supplement containing green-lipped mussel, curcumin and blackcurrant leaf extract in dogs and cats with osteoarthritis. →
Study · Accessed 2026-11-14
- 6. Evaluating Complementary Therapies for Canine Osteoarthritis Part I: Green-lipped Mussel (Perna canaliculus). →
Study · Accessed 2026-11-14
- 7. Evaluation of the comparative efficacy of green lipped mussel plus krill oil extracts (EAB-277), <i>Biota orientalis</i> extracts or NSAIDs for the treatment of dogs with osteoarthritis associated pain: a blinded, placebo-controlled study. →
Study · Accessed 2026-11-14
- 8. Chondroprotective Effect of PCSO-524 (Green-Lipped Mussel Extraction) Application Evaluated by Ultrasonography in Pomeranian and Chihuahua With Medial Patellar Luxation Grade II. →
Study · Accessed 2026-11-14
- 9. Effects of a feed supplement, containing undenatured type II collagen (UC II®) and Boswellia Serrata, in the management of mild/moderate mobility disorders in dogs: A randomized, double-blind, placebo controlled, cross-over study. →
Study · Accessed 2026-11-04
- 10. Dietary support with Boswellia resin in canine inflammatory joint and spinal disease. →
Study · Accessed 2026-11-04
- 11. Heat-Treated <i>Lacticaseibacillus rhamnosus</i> Strains Modulate Inflammatory and Metabolic Processes in <i>In Vitro</i> Systems Relevant to Canine Osteoarthritis. →
Study · Accessed 2026-11-14
How this report was produced
AI-assisted evidence analysis. We reviewed published material, not physical products.
Automated source and evidence checks completed on 2026-11-14. These checks are not veterinary review.
Research scope and outstanding checks
Searched a literature index with eight queries: nutraceutical osteoarthritis systematic reviews in dogs, the product name, Boswellia serrata, and PRIOME postbiotic, each with a most-cited variant. Many sources were abstract-only, so methods, doses and funding were often unavailable. Not exhaustive. Excluded from dog evidence rows: the mouse part of the curcumin-glucosamine-chondroitin paper (pmid40431555), cat data in mixed studies, the pooled dog-and-cat 2022 meta-analysis (pmid36142319, cited as context only), a PRIOME JH lab and worm study on a different strain (pmid41744779), a vet survey, a mesotherapy study and the Boswellia assay paper. Manufacturer claims are not clinical evidence.
Focused research searches:
- (TITLE_ABS:nutraceutical* AND TITLE_ABS:osteoarthrit* AND TITLE_ABS:systematic AND TITLE_ABS:review) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine)
- (TITLE_ABS:nutraceutical* AND TITLE_ABS:osteoarthrit* AND TITLE_ABS:systematic AND TITLE_ABS:review) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine) sort_cited:y
- (Fera AND Pets AND Hip AND Joint) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine)
- (Fera AND Pets AND Hip AND Joint) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine) sort_cited:y
- (TITLE_ABS:Boswellia AND TITLE_ABS:Serrata AND TITLE_ABS:osteoarthrit*) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine)
- (TITLE_ABS:Boswellia AND TITLE_ABS:Serrata AND TITLE_ABS:osteoarthrit*) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine) sort_cited:y
- (TITLE_ABS:PRIOME AND TITLE_ABS:Metabolic AND TITLE_ABS:Health AND TITLE_ABS:Postbiotic AND TITLE_ABS:osteoarthrit*) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine)
- (TITLE_ABS:PRIOME AND TITLE_ABS:Metabolic AND TITLE_ABS:Health AND TITLE_ABS:Postbiotic AND TITLE_ABS:osteoarthrit*) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine) sort_cited:y
- No trial of this exact chew was found in this search.
- No dog evidence for MSM was found in the retrieved texts.
- No dog study of the PRIOME B. animalis postbiotic and body weight was found.
- No named lab, certificate or batch test result for the '3rd Party Tested' claim.
- No sulfate-versus-HCl glucosamine comparison in dogs in the reviewed sources.
- No dog-only results for glucosamine-chondroitin were available in the supplied text of the 2022 pooled review.